Skip to main content
. 2022 Aug 9;13:927481. doi: 10.3389/fneur.2022.927481

Table 1.

Demographic data of the participants.

Healthy controls Parkinson's disease
N 16 15
Age (mean +/- SD) 64.63 +/- 8.84 65.34 +/- 6.81
Sex (male/female) 8/9 11/4
UPDRSIII-motor (mean +/- SD) - 25.00 +/- 9.82
Hoehn-Yahr stage (median, range) - 3 (1–4)
Disease duration (years, mean +/- SD) - 8.13 +/- 5.82 (1–20)
Levodopa equivalent daily dose (LEDD; mean +/- SD, range) - 798.27 +/- 483.95 (0–1,800)
Dominant side of motor symptoms (R: right, L: left, B: both) - 7R,7L,1B